Neurobiology Group, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411008, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Neurobiology Group, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411008, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Eur J Cell Biol. 2022 Apr;101(2):151201. doi: 10.1016/j.ejcb.2022.151201. Epub 2022 Jan 25.
In Alzheimer's disease, the microtubule-associated protein, Tau misfolds to form aggregates and filaments in the intra- and extracellular region of neuronal cells. Microglial cells are the resident brain macrophage cells involved in constant surveillance and activated by the extracellular deposits. Purinergic receptors are involved in the chemotactic migration of microglial cells towards the site of inflammation. From our recent study, we have observed that the microglial P2Y12 receptor is involved in phagocytosis of full-length Tau species such as monomers, oligomers and aggregates by actin-driven chemotaxis. This study shows the interaction of repeat-domain of Tau (Tau) with the microglial P2Y12 receptor and the corresponding residues for interaction have been analysed by various in-silico approaches. In the cellular studies, Tau was found to interact with microglial P2Y12R and induces its cellular expression confirmed by co-immunoprecipitation and western blot analysis. Furthermore, the P2Y12R-mediated Tau internalization has demonstrated activation of microglia with an increase in the Iba1 level, and Tau becomes accumulated at the peri-nuclear region for the degradation. Similarly, immunofluorescence microscopic studies emphasized that Tau is phagocytosed by microglial P2Y12R via the membrane-associated actin remodeling as filopodia extension. Upon internalization, we have demonstrated the P2Y12R signaling-mediated degradation of accumulated Tau by lysosomal pathway. Altogether, microglial P2Y12R interacts with Tau and mediates directed migration and activation for its internalization and degradation.
在阿尔茨海默病中,微管相关蛋白 Tau 错误折叠形成聚集体和原纤维,存在于神经元细胞的细胞内和细胞外区域。小胶质细胞是驻留于脑内的巨噬细胞,参与持续监测,并被细胞外沉积物激活。嘌呤能受体参与小胶质细胞向炎症部位趋化性迁移。从我们最近的研究中,我们观察到小胶质细胞 P2Y12 受体参与全长 Tau 物种(如单体、寡聚体和聚集体)的吞噬作用,这种吞噬作用是由肌动蛋白驱动的趋化作用引起的。本研究显示 Tau 的重复结构域(Tau)与小胶质细胞 P2Y12 受体相互作用,并通过各种计算方法分析了相互作用的相应残基。在细胞研究中,发现 Tau 与小胶质细胞 P2Y12R 相互作用,并通过共免疫沉淀和 Western blot 分析证实其诱导细胞表达。此外,P2Y12R 介导的 Tau 内化激活了小胶质细胞,Iba1 水平增加,Tau 在内核周围区域积累并降解。同样,免疫荧光显微镜研究强调 Tau 通过膜相关肌动蛋白重塑被小胶质细胞 P2Y12R 吞噬,表现为丝状伪足延伸。内化后,我们通过溶酶体途径证明了 P2Y12R 信号介导的 Tau 积累降解。总之,小胶质细胞 P2Y12R 与 Tau 相互作用,介导定向迁移和激活,从而内化和降解 Tau。